Clinical and pharmacological group: & nbsp

Other non-narcotic analgesics, including non-steroidal and other anti-inflammatory drugs

Antiseptics and disinfectants

Dermatotropona funds

Included in the formulation
  • Naftaderm®
    liniment locally 
  • АТХ:

    D.08.A.X   Other antiseptics and disinfectants

    Pharmacodynamics:

    Means for topical application. Has analgesic, emollient, absorbable and antiseptic effect.

    Pharmacokinetics:

    Means for topical application, systemic action on the body does not have.

    Indications:

    It is used for the treatment of eczema, seborrhea, pink lichen, psoriasis, pyoderma, neurodermatitis. Used for bedsores, poorly healing wounds, erysipelas.

    I.A30-A49.A46   Erys

    XII.L00-L08.L02   Abscess of skin, boil and carbuncle

    XII.L00-L08.L08.0   Pyoderma

    XII.L20-L30.L20.8   Other atopic dermatitis

    XII.L20-L30.L21   Seborrheic dermatitis

    XII.L20-L30.L28   Simple chronic lichen and prurigo

    XII.L40-L45.L40   Psoriasis

    XII.L80-L99.L89   Decubital ulcer

    XII.L80-L99.L90   Atrophic skin lesions

    Contraindications:

    Hemorrhagic syndrome, age up to 3 years, individual intolerance.

    Carefully:

    Chronic renal failure.

    Pregnancy and lactation:

    Recommendations for FDA - Category B. It is used in pregnancy and lactation.

    Dosing and Administration:

    Outerly, a thin layer, not rubbing into the skin, 2 times a day.

    Side effects:

    Dry skin, rarely - folliculitis. Allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.
    Interaction:

    Clinically significant interactions are not described.

    Special instructions:

    When skin dryness is recommended, softening creams are recommended.

    Instructions
    Up